A Monash University study published in Nature Communications finds that an antibiotic resistance gene lets Clostridioides difficile keep forming spores tough enough to withstand hospital-grade cleaning products and high laundry temperatures.
Antibiotic resistance is helping Clostridioides difficile produce hardier spores that can survive the hospital-grade disinfectants meant to kill them, according to new research from Monash University in Australia.
The study,
The finding is particularly concerning because C. difficile is common in hospitals and causes diarrhea that can be deadly for patients who are already ill. The bacterium's spores function much like plant seeds, lying dormant until they reach a favorable environment, such as the human gut, where they activate and spread.
According to the researchers, certain antibiotics normally block C. difficile from forming spores. When the bacterium picks up this resistance gene, that block no longer works.
The gene produces a protein that takes the place of a key spore-building protein, allowing the bacterium to continue making spores. The resulting spores are tougher than usual, able to survive hospital-grade cleaning products and high laundry temperatures.
Lead researcher Dena Lyras, interim dean of the Monash Sub-Faculty of Biomedical and Psychological Sciences and director of the Monash Biomedicine Discovery Institute, called the research a crucial step forward in a fast-moving race against
"Antibiotics are helping bacteria evolve in ways we hadn't anticipated," Lyras said. "Our new research shows just how sophisticated their evolution is, with the potential to have disastrous impacts on humans."
She added that the bacteria "are not only better at building tolerance to drugs we develop, but making new versions of themselves that can survive better in particular environments, like surfaces where cleaning products are commonly applied."
First author Yogitha Srikhanta, a postdoctoral research fellow at the Monash Biomedicine Discovery Institute, said the spores themselves may be the most promising target for a solution.
"Spore survival matters because spores are the main way these pathogens spread between people and through hospitals, homes, and the environment," Srikhanta said.
"A resistance gene that changes how spores are built could make infections harder to control and help resistant strains spread more easily," she said. "We are now investigating ways to deal with this new type of antibiotic resistance."
Antimicrobial resistance occurs when bacteria stop responding to antibiotics, leading to infections that are difficult or impossible to treat. The World Health Organization lists antimicrobial resistance as a major global health threat and estimates it contributes to millions of deaths each year.
The Monash findings add a new wrinkle to a problem infection control teams have long recognized: C. difficile is unusually hard to eliminate from the care environment. Because its spores are dormant and resilient, they can persist on surfaces, equipment and linens long after an infected patient has been discharged, creating opportunities for transmission to the next patient.
That persistence is why infection prevention protocols for C. difficile typically differ from those used for many other pathogens. Alcohol-based hand sanitizers, which are effective against many bacteria and viruses, are generally considered unreliable against C. difficile spores, so handwashing with soap and water is commonly emphasized when caring for infected patients. Many facilities also rely on sporicidal cleaning agents and contact precautions to limit spread.
Research showing that spores may become harder to kill raises questions about whether current cleaning and laundering practices will remain sufficient over time, particularly as resistant strains circulate. It also underscores the connection between prescribing decisions and environmental risk: antibiotic exposure disrupts the protective gut microbiome, creating the conditions in which C. difficile can take hold, and broader antibiotic use creates selective pressure favoring resistant strains.
For practices outside the hospital, the implications are practical. Patients move frequently between hospitals, skilled nursing facilities and outpatient settings, and C. difficile can travel with them. Physicians can support
As investigators work to understand how resistance genes reshape bacterial survival strategies, stewardship and infection control are likely to remain the most immediate tools available to clinicians.
